Unicorn Fund Crosses 5% Threshold with 6.5883% Stake Acquisition in Accretion Nutraveda Limited
Unicorn Fund has acquired 477000 equity shares in Accretion Nutraveda Limited, representing 6.5883% of the company's paid-up equity capital and crossing the 5% regulatory threshold. The acquisition was completed through IPO participation (471000 shares) and secondary market purchases (6000 shares) between February 4-5, 2026. The company has made the mandatory disclosure to BSE Limited pursuant to SEBI regulations, with Unicorn Fund classified as a non-promoter investor.
